Thomas Jefferson University, Investigational Drug Service — Philadelphia, Pennsylvania

Thomas Jefferson University, Investigational Drug Service is a clinical research site located in Philadelphia, Pennsylvania, United States 19107.

Crixeo Health Trust Score: 47/100 (POOR). This profile has not yet been claimed by the site owner.

Thomas Jefferson University, Investigational Drug Service has participated in 1 clinical trials.

Therapeutic areas: Lymphoma, Multiple Myeloma, Acute Myeloid Leukemia.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 47/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Thomas Jefferson University, Investigational Drug Service?

Thomas Jefferson University, Investigational Drug Service has a Crixeo Trust Score of 47/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Thomas Jefferson University, Investigational Drug Service conducted?

Thomas Jefferson University, Investigational Drug Service has 1 clinical trials on record. Their work covers Lymphoma, Multiple Myeloma, Acute Myeloid Leukemia.

Is Thomas Jefferson University, Investigational Drug Service accredited by Crixeo Health?

Thomas Jefferson University, Investigational Drug Service has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Thomas Jefferson University, Investigational Drug Service?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.